000			01467 a2200433 4500
005			20250513150032.0
264		0	_c19980929
008			199809s 0 0 eng d
022			_a0968-0896
024	7		_a10.1016/s0968-0896(98)00037-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aValenti, P
245	0	0	_aCoumarin 1,4-dihydropyridine derivatives. _h[electronic resource]
260			_bBioorganic & medicinal chemistry _cJun 1998
300			_a803-10 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAorta _xdrug effects
650	0	4	_aCalcium Channel Blockers _xchemical synthesis
650	0	4	_aCoumarins _xchemical synthesis
650	0	4	_aDepression, Chemical
650	0	4	_aDihydropyridines _xchemical synthesis
650	0	4	_aFemale
650	0	4	_aGuinea Pigs
650	0	4	_aHeart _xdrug effects
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aIn Vitro Techniques
650	0	4	_aMale
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aStereoisomerism
650	0	4	_aStructure-Activity Relationship
650	0	4	_aVasodilator Agents _xchemical synthesis
700	1		_aRampa, A
700	1		_aBudriesi, R
700	1		_aBisi, A
700	1		_aChiarini, A
773	0		_tBioorganic & medicinal chemistry _gvol. 6 _gno. 6 _gp. 803-10
856	4	0	_uhttps://doi.org/10.1016/s0968-0896(98)00037-6 _zAvailable from publisher's website
999			_c9646920 _d9646920